Incidence of induced hypertension in pregnancy in Health Area IV in the Cienfuegos municipality in the period from 2017 to 2018

Ismary Rodríguez Crespo, José Carlos Gómez Machado, Álvaro Lissabet Magaña, Marcell Valdés Martín, Deyanis Ercía Rodríguez, Juan Andrés Alemañy Co

Resumen

Introduction: hypertensive disorders of pregnancy are an important health problem throughout the world, which have an incidence between 10 and 15 % of full-term pregnant women, which is why they constitute one of the main causes of maternal morbidity and mortality and perinatal, these disorders can be reduced by early and careful care of high-risk patients.

Objective: to determine the incidence of induced hypertension in pregnancy in Health Area IV in the Cienfuegos municipality in the period from 2017 to 2018.

Methods: a retrospective descriptive study of 29 pregnant patients was carried out, between the years 2017 and 2018, treated in Health Area IV in the municipality of Cienfuegos, using their medical records. The sample consisted of the 18 pregnant women who developed hypertension during pregnancy. Variables were used such as the classification of patients according to the type of arterial hypertension, gestational age at the end of pregnancy, maternal morbidity and the treatment used. Statistical analysis was performed with percentages and the results were expressed using tables.

Results: pregnancy-induced arterial hypertension represented 55,55 % of this group and non-aggravated preeclampsia predominated with 61,1 %. The interruption of pregnancy was more frequent between 38 and 41 weeks of gestation, which represents 44,44 %. Maternal morbidity was high, representing 72,22 %. The treatment of choice was methyldopa associated with sedation, constituting 72,22 %.

Conclusions: hypertensive disorders of pregnancy are an important public health problem. Studies have shown that pregnancy-induced hypertension is a disease that progressively complicates pregnancy, causing serious maternal and perinatal consequences.

Palabras clave

hypertension; pregnancy; morbidity; treatment

Referencias

Rigol Ricardo O. Obstetricia y ginecología. La Habana: Editorial Ciencias Médicas, 2016:237-52.

Bryce Moncloa A, Alegría Valdivia E, Valenzuela Rodríguez G, Larrauri Vigna CA, Urquiaga Calderón J, San Martín San Martín MG. Hipertensión en el embarazo. Rev Peru Ginecol Obstet [Internet]. 16 de julio de 2018 [citado 5 de setiembre de 2019];64(2):191-6. Disponible en: http://www.spog.org.pe/web/revista/index.php/RPGO/article/view/2077

American College of Obstetricians and Gynecologists. ACOG Guidelines: Hypertension in pregnancy. American College of Obstetricians and Gynecologists. 2017. p.1-100.

Rosas-Peralta M et al. Hipertensión arterial y embarazo: el reto continúa. Rev Med Inst Mex Seguro Soc [Internet]. 2016 [Consultado08/03/2017];54:S90-111 Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=67447

Zhang J, Zeisler J, Hatch MC, Berkowitz G. Epidemiology of pregnancy-induced hypertension. Epidemiol Rev. 2016; 19:218–32.

Beltran Chaparro, L.V.; Benavides, P.; Lopez Rios, J.A.; Onatra Herrera, W. Estados hipertensivos en el embarazo: Revision. Rev. U.D.C.A Act. & Div. Cient.2014; 17(2): 311-323.

Robers J, August P, Bakris G, Barton J, Bernstein I, Druzin M et al. Hypertension in Pregnancy Report of the American College of Obstetricians and Gynecologists’. Task Force on Hypertension in Pregnancy. OBSTETRICS & GYNECOLOGY (2016); 122 (5): 1122-1131.

GBD Compare | IHME Viz Hub [Internet]. [citado 4 de setiembre de 2019]. Disponible en: http://vizhub.healthdata.org/gbd-compare

ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstet Gynecol [Internet]. Enero de 2019 [citado 2 de septiembre de 2019];133(1):e1. Disponible en: https://journals.lww.com/greenjournal/Fulltext/2019/01000/ACOG_Practice_Bulletin_No__202_ _Gestational.49.aspx

Pérez Caballero MD, León Álvarez JL, Dueñas Herrera A, Alfonzo Guerra JP, Navarro Despaigne DA, de la Noval García R, et al. Guía cubana de diagnóstico, evaluación y tratamiento de la hipertensión arterial*. Rev Cuba Med [Internet]. Diciembre de 2017 [citado 5 de setiembre de 2019];56(4):242-321. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_abstract&pid=S003475232017000400001&lng=es&nrm=iso&tlng=en

GBD Compare | IHME Viz Hub [Internet]. [citado 4 de setiembre de 2019]. Disponible en: http://vizhub.healthdata.org/gbd-compare

Guía ESC/ESH 2018 sobre el diagnóstico y tratamiento de la hipertensión arterial [Internet]. [citado 8 de setiembre de 2019]. Disponible en: https://www.revespcardiol.org/es-pdfS0300893218306791

Magee LA, Pels A, Helewa M, et al. Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy: Executive Summary. Pregnancy Hypertens. 2014 Apr;4(2):105-45. Citado en PubMed:PMID:26104418.

Akihide O, Hirashima C, Takahashi K, et al. Prediction and prevention of hypertensive disorders of pregnancy. Hypertens Res. 2017;40(1):5–14. Citado en PubMed:PMID:27534740.

Cooray SD, Edmonds SM, Tong S, Samarasekera SP, Whitehead CL. Characterization of symptoms immediately preceding eclampsia. Obstet Gynecol. noviembre de 2017;118(5):9959.

Enlaces refback

  • No hay ningún enlace refback.